BioNTech SE - ADR vs GoPro Inc — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while GoPro Inc trades at $0.62 (market cap $114.41M). The key difference: BioNTech SE - ADR is far larger — about 203.7× GoPro Inc's market cap, and BioNTech SE - ADR is trading nearer its 52-week high, GoPro Inc nearer its low. Which is the better fit depends on your goals.
| BNTX | GPRO | |
|---|---|---|
Market Cap | $23.31B | $114.41M |
Sector | Health | Technology |
52-Week High | $119.34 | $2.88 |
52-Week Low | $83.89 | $0.62 |
Enterprise Value | $6.60B | $173.19M |
Trailing returns across standard periods
Latest headlines on both assets
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts, drones and appliances. The company outsources a part of manufacturing to third parties in China. The company sells products across the world through its direct sales channel, which generates over half of total revenue, and indirectly through its distribution channel. The company has presence, including in the Americas, Europe, Middle East, Africa, and Asia-Pacific, with the Americas contributing over half of total revenue.
Read more on GPRO →